Global Tuberculosis Prevention and Treatment Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu?rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
LPI (LP Information)' newest research report, the “Tuberculosis Prevention and Treatment Vaccine Industry Forecast” looks at past sales and reviews total world Tuberculosis Prevention and Treatment Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Tuberculosis Prevention and Treatment Vaccine sales for 2023 through 2029. With Tuberculosis Prevention and Treatment Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Prevention and Treatment Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Tuberculosis Prevention and Treatment Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Prevention and Treatment Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tuberculosis Prevention and Treatment Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Prevention and Treatment Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Prevention and Treatment Vaccine.
The global Tuberculosis Prevention and Treatment Vaccine market size is projected to grow from US$ 72 million in 2022 to US$ 100.3 million in 2029; it is expected to grow at a CAGR of 100.3 from 2023 to 2029.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Prevention and Treatment Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Tuberculosis Prevention and Treatment Vaccine market?
What factors are driving Tuberculosis Prevention and Treatment Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tuberculosis Prevention and Treatment Vaccine market opportunities vary by end market size?
How does Tuberculosis Prevention and Treatment Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu?rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
LPI (LP Information)' newest research report, the “Tuberculosis Prevention and Treatment Vaccine Industry Forecast” looks at past sales and reviews total world Tuberculosis Prevention and Treatment Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Tuberculosis Prevention and Treatment Vaccine sales for 2023 through 2029. With Tuberculosis Prevention and Treatment Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Prevention and Treatment Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Tuberculosis Prevention and Treatment Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Prevention and Treatment Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tuberculosis Prevention and Treatment Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Prevention and Treatment Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Prevention and Treatment Vaccine.
The global Tuberculosis Prevention and Treatment Vaccine market size is projected to grow from US$ 72 million in 2022 to US$ 100.3 million in 2029; it is expected to grow at a CAGR of 100.3 from 2023 to 2029.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Prevention and Treatment Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Immune Vaccine
- Therapy Vaccine
- Self-Procurement
- UNICEF
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Japan BCG Lab
- Serum Institute of India
- AJ Vaccines
- BioFarma
- GreenSignal Bio Pharma
- China National Biotec
- Biomed Lublin
- Taj Pharmaceuticals
- Ataulpho de Paiva
- IVAC
- Queen Saovabha Mem. Inst
- Microgen
What is the 10-year outlook for the global Tuberculosis Prevention and Treatment Vaccine market?
What factors are driving Tuberculosis Prevention and Treatment Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tuberculosis Prevention and Treatment Vaccine market opportunities vary by end market size?
How does Tuberculosis Prevention and Treatment Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Tuberculosis Prevention and Treatment Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Tuberculosis Prevention and Treatment Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Tuberculosis Prevention and Treatment Vaccine Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 Tuberculosis Prevention and Treatment Vaccine Sales by Type
2.3.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Type (2018-2023)
2.4 Tuberculosis Prevention and Treatment Vaccine Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Other
2.5 Tuberculosis Prevention and Treatment Vaccine Sales by Application
2.5.1 Global Tuberculosis Prevention and Treatment Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Application (2018-2023)
3 GLOBAL TUBERCULOSIS PREVENTION AND TREATMENT VACCINE BY COMPANY
3.1 Global Tuberculosis Prevention and Treatment Vaccine Breakdown Data by Company
3.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Company (2018-2023)
3.2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Company
3.4 Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Product Location Distribution
3.4.2 Players Tuberculosis Prevention and Treatment Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TUBERCULOSIS PREVENTION AND TREATMENT VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Tuberculosis Prevention and Treatment Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Tuberculosis Prevention and Treatment Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Tuberculosis Prevention and Treatment Vaccine Sales Growth
4.4 APAC Tuberculosis Prevention and Treatment Vaccine Sales Growth
4.5 Europe Tuberculosis Prevention and Treatment Vaccine Sales Growth
4.6 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Growth
5 AMERICAS
5.1 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country
5.1.1 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023)
5.1.2 Americas Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023)
5.2 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Type
5.3 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region
6.1.1 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region (2018-2023)
6.1.2 APAC Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2018-2023)
6.2 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Type
6.3 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tuberculosis Prevention and Treatment Vaccine by Country
7.1.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023)
7.1.2 Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023)
7.2 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type
7.3 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine by Country
8.1.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type
8.3 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tuberculosis Prevention and Treatment Vaccine
10.3 Manufacturing Process Analysis of Tuberculosis Prevention and Treatment Vaccine
10.4 Industry Chain Structure of Tuberculosis Prevention and Treatment Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tuberculosis Prevention and Treatment Vaccine Distributors
11.3 Tuberculosis Prevention and Treatment Vaccine Customer
12 WORLD FORECAST REVIEW FOR TUBERCULOSIS PREVENTION AND TREATMENT VACCINE BY GEOGRAPHIC REGION
12.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Region
12.1.1 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Region (2024-2029)
12.1.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Type
12.7 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC
13.11.1 IVAC Company Information
13.11.2 IVAC Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 IVAC Main Business Overview
13.11.5 IVAC Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Tuberculosis Prevention and Treatment Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Tuberculosis Prevention and Treatment Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Tuberculosis Prevention and Treatment Vaccine Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 Tuberculosis Prevention and Treatment Vaccine Sales by Type
2.3.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Type (2018-2023)
2.4 Tuberculosis Prevention and Treatment Vaccine Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Other
2.5 Tuberculosis Prevention and Treatment Vaccine Sales by Application
2.5.1 Global Tuberculosis Prevention and Treatment Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Application (2018-2023)
3 GLOBAL TUBERCULOSIS PREVENTION AND TREATMENT VACCINE BY COMPANY
3.1 Global Tuberculosis Prevention and Treatment Vaccine Breakdown Data by Company
3.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Company (2018-2023)
3.2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Company
3.4 Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Product Location Distribution
3.4.2 Players Tuberculosis Prevention and Treatment Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TUBERCULOSIS PREVENTION AND TREATMENT VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Tuberculosis Prevention and Treatment Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Tuberculosis Prevention and Treatment Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Tuberculosis Prevention and Treatment Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Tuberculosis Prevention and Treatment Vaccine Sales Growth
4.4 APAC Tuberculosis Prevention and Treatment Vaccine Sales Growth
4.5 Europe Tuberculosis Prevention and Treatment Vaccine Sales Growth
4.6 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Growth
5 AMERICAS
5.1 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country
5.1.1 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023)
5.1.2 Americas Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023)
5.2 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Type
5.3 Americas Tuberculosis Prevention and Treatment Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region
6.1.1 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region (2018-2023)
6.1.2 APAC Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2018-2023)
6.2 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Type
6.3 APAC Tuberculosis Prevention and Treatment Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tuberculosis Prevention and Treatment Vaccine by Country
7.1.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023)
7.1.2 Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023)
7.2 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type
7.3 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine by Country
8.1.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type
8.3 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tuberculosis Prevention and Treatment Vaccine
10.3 Manufacturing Process Analysis of Tuberculosis Prevention and Treatment Vaccine
10.4 Industry Chain Structure of Tuberculosis Prevention and Treatment Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tuberculosis Prevention and Treatment Vaccine Distributors
11.3 Tuberculosis Prevention and Treatment Vaccine Customer
12 WORLD FORECAST REVIEW FOR TUBERCULOSIS PREVENTION AND TREATMENT VACCINE BY GEOGRAPHIC REGION
12.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Region
12.1.1 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Region (2024-2029)
12.1.2 Global Tuberculosis Prevention and Treatment Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Type
12.7 Global Tuberculosis Prevention and Treatment Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC
13.11.1 IVAC Company Information
13.11.2 IVAC Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 IVAC Main Business Overview
13.11.5 IVAC Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
13.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tuberculosis Prevention and Treatment Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Tuberculosis Prevention and Treatment Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Immune Vaccine
Table 4. Major Players of Therapy Vaccine
Table 5. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2018-2023)
Table 13. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Tuberculosis Prevention and Treatment Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Producing Area Distribution and Sales Area
Table 21. Players Tuberculosis Prevention and Treatment Vaccine Products Offered
Table 22. Tuberculosis Prevention and Treatment Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tuberculosis Prevention and Treatment Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Tuberculosis Prevention and Treatment Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Tuberculosis Prevention and Treatment Vaccine
Table 58. Key Market Challenges & Risks of Tuberculosis Prevention and Treatment Vaccine
Table 59. Key Industry Trends of Tuberculosis Prevention and Treatment Vaccine
Table 60. Tuberculosis Prevention and Treatment Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Tuberculosis Prevention and Treatment Vaccine Distributors List
Table 63. Tuberculosis Prevention and Treatment Vaccine Customer List
Table 64. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 80. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Japan BCG Lab Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 85. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Japan BCG Lab Main Business
Table 87. Japan BCG Lab Latest Developments
Table 88. Serum Institute of India Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 90. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Serum Institute of India Main Business
Table 92. Serum Institute of India Latest Developments
Table 93. AJ Vaccines Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 95. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. AJ Vaccines Main Business
Table 97. AJ Vaccines Latest Developments
Table 98. BioFarma Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. BioFarma Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 100. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. BioFarma Main Business
Table 102. BioFarma Latest Developments
Table 103. GreenSignal Bio Pharma Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 105. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. GreenSignal Bio Pharma Main Business
Table 107. GreenSignal Bio Pharma Latest Developments
Table 108. China National Biotec Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 110. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. China National Biotec Main Business
Table 112. China National Biotec Latest Developments
Table 113. Biomed Lublin Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 115. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Biomed Lublin Main Business
Table 117. Biomed Lublin Latest Developments
Table 118. Taj Pharmaceuticals Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 120. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Taj Pharmaceuticals Main Business
Table 122. Taj Pharmaceuticals Latest Developments
Table 123. Ataulpho de Paiva Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 125. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Ataulpho de Paiva Main Business
Table 127. Ataulpho de Paiva Latest Developments
Table 128. IVAC Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. IVAC Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 130. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. IVAC Main Business
Table 132. IVAC Latest Developments
Table 133. Queen Saovabha Mem. Inst Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 135. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Queen Saovabha Mem. Inst Main Business
Table 137. Queen Saovabha Mem. Inst Latest Developments
Table 138. Microgen Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Microgen Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 140. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Microgen Main Business
Table 142. Microgen Latest Developments
Table 1. Tuberculosis Prevention and Treatment Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Tuberculosis Prevention and Treatment Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Immune Vaccine
Table 4. Major Players of Therapy Vaccine
Table 5. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2018-2023)
Table 13. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Tuberculosis Prevention and Treatment Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Tuberculosis Prevention and Treatment Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Producing Area Distribution and Sales Area
Table 21. Players Tuberculosis Prevention and Treatment Vaccine Products Offered
Table 22. Tuberculosis Prevention and Treatment Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tuberculosis Prevention and Treatment Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Tuberculosis Prevention and Treatment Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Tuberculosis Prevention and Treatment Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Tuberculosis Prevention and Treatment Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Tuberculosis Prevention and Treatment Vaccine
Table 58. Key Market Challenges & Risks of Tuberculosis Prevention and Treatment Vaccine
Table 59. Key Industry Trends of Tuberculosis Prevention and Treatment Vaccine
Table 60. Tuberculosis Prevention and Treatment Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Tuberculosis Prevention and Treatment Vaccine Distributors List
Table 63. Tuberculosis Prevention and Treatment Vaccine Customer List
Table 64. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Tuberculosis Prevention and Treatment Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 80. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Japan BCG Lab Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 85. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Japan BCG Lab Main Business
Table 87. Japan BCG Lab Latest Developments
Table 88. Serum Institute of India Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 90. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Serum Institute of India Main Business
Table 92. Serum Institute of India Latest Developments
Table 93. AJ Vaccines Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 95. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. AJ Vaccines Main Business
Table 97. AJ Vaccines Latest Developments
Table 98. BioFarma Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. BioFarma Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 100. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. BioFarma Main Business
Table 102. BioFarma Latest Developments
Table 103. GreenSignal Bio Pharma Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 105. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. GreenSignal Bio Pharma Main Business
Table 107. GreenSignal Bio Pharma Latest Developments
Table 108. China National Biotec Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 110. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. China National Biotec Main Business
Table 112. China National Biotec Latest Developments
Table 113. Biomed Lublin Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 115. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Biomed Lublin Main Business
Table 117. Biomed Lublin Latest Developments
Table 118. Taj Pharmaceuticals Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 120. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Taj Pharmaceuticals Main Business
Table 122. Taj Pharmaceuticals Latest Developments
Table 123. Ataulpho de Paiva Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 125. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Ataulpho de Paiva Main Business
Table 127. Ataulpho de Paiva Latest Developments
Table 128. IVAC Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. IVAC Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 130. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. IVAC Main Business
Table 132. IVAC Latest Developments
Table 133. Queen Saovabha Mem. Inst Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 135. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Queen Saovabha Mem. Inst Main Business
Table 137. Queen Saovabha Mem. Inst Latest Developments
Table 138. Microgen Basic Information, Tuberculosis Prevention and Treatment Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Microgen Tuberculosis Prevention and Treatment Vaccine Product Portfolios and Specifications
Table 140. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Microgen Main Business
Table 142. Microgen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tuberculosis Prevention and Treatment Vaccine
Figure 2. Tuberculosis Prevention and Treatment Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tuberculosis Prevention and Treatment Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Tuberculosis Prevention and Treatment Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Immune Vaccine
Figure 10. Product Picture of Therapy Vaccine
Figure 11. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type in 2022
Figure 12. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Tuberculosis Prevention and Treatment Vaccine Consumed in Self-Procurement
Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Market: Self-Procurement (2018-2023) & (K Units)
Figure 15. Tuberculosis Prevention and Treatment Vaccine Consumed in UNICEF
Figure 16. Global Tuberculosis Prevention and Treatment Vaccine Market: UNICEF (2018-2023) & (K Units)
Figure 17. Tuberculosis Prevention and Treatment Vaccine Consumed in Other
Figure 18. Global Tuberculosis Prevention and Treatment Vaccine Market: Other (2018-2023) & (K Units)
Figure 19. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2022)
Figure 20. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application in 2022
Figure 21. Tuberculosis Prevention and Treatment Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Company in 2022
Figure 23. Tuberculosis Prevention and Treatment Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Tuberculosis Prevention and Treatment Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Tuberculosis Prevention and Treatment Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Tuberculosis Prevention and Treatment Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Tuberculosis Prevention and Treatment Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Tuberculosis Prevention and Treatment Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Tuberculosis Prevention and Treatment Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Tuberculosis Prevention and Treatment Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Tuberculosis Prevention and Treatment Vaccine
Figure 74. Industry Chain Structure of Tuberculosis Prevention and Treatment Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Tuberculosis Prevention and Treatment Vaccine
Figure 2. Tuberculosis Prevention and Treatment Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tuberculosis Prevention and Treatment Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Tuberculosis Prevention and Treatment Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Immune Vaccine
Figure 10. Product Picture of Therapy Vaccine
Figure 11. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type in 2022
Figure 12. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Tuberculosis Prevention and Treatment Vaccine Consumed in Self-Procurement
Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Market: Self-Procurement (2018-2023) & (K Units)
Figure 15. Tuberculosis Prevention and Treatment Vaccine Consumed in UNICEF
Figure 16. Global Tuberculosis Prevention and Treatment Vaccine Market: UNICEF (2018-2023) & (K Units)
Figure 17. Tuberculosis Prevention and Treatment Vaccine Consumed in Other
Figure 18. Global Tuberculosis Prevention and Treatment Vaccine Market: Other (2018-2023) & (K Units)
Figure 19. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2022)
Figure 20. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application in 2022
Figure 21. Tuberculosis Prevention and Treatment Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Company in 2022
Figure 23. Tuberculosis Prevention and Treatment Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Tuberculosis Prevention and Treatment Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Tuberculosis Prevention and Treatment Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Tuberculosis Prevention and Treatment Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Tuberculosis Prevention and Treatment Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Tuberculosis Prevention and Treatment Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Tuberculosis Prevention and Treatment Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Tuberculosis Prevention and Treatment Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Tuberculosis Prevention and Treatment Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Tuberculosis Prevention and Treatment Vaccine
Figure 74. Industry Chain Structure of Tuberculosis Prevention and Treatment Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share Forecast by Application (2024-2029)
